Medical device company stocks are not looking as rosy as they did two months ago, but the medtech industry still appears to be resisting the overall downward trend in stock markets, according to a Medical Design & Outsourcing analysis. The company's medical device segment makes most of its revenue from surgical products, with growth fueled primarily by wound care and advanced sterilization products. As of Dec. 31, 2018, Tandem had cash, cash equivalents, and short-term investments of $129 million. Intuitive Surgical pioneered the use of robotic surgical systems with its da Vinci system. At the bottom is the transcatheter mitral and tricuspid therapies product group, which adds less than 1% of total revenue. Others specialize in niche markets. For a small number of Class I devices, though, a regulatory filing called a 510(k) notification must be submitted to the FDA. “For the most part, medical device companies are in good shape,” Denhoy said. Around 25,000 of its Impella heart pumps are implanted in patients annually. And these markets continue to grow as the country's populations age. First, it has a large base of customers who are motivated to maximize their return on investment with da Vinci rather than look for a new system. Bard. Issuing new shares dilutes the value of existing shares. Several of the companies also could be hurt if global trade issues aren't resolved. Just a few get by through only registering with the FDA, while most require the filing of a 510(k) notification. Stryker is another company that makes all of its revenue from medical devices. The U.S. Food and Drug Administration (FDA) defines a medical device in broad terms. Class I devices usually only require registering with the FDA, and there's no approval process. Illumina should deliver strong growth as demand for genomic sequencing expands, especially in the areas of cancer diagnostics and treatment. While some competitors have entered the clear aligner market, Align Technology isn't too worried about them. With new products on the way to treat more difficult cases, Align should be able to expand its addressable market significantly as well. Why IHI? 1. Returns as of 12/09/2020. Johnson & Johnson isn't just the biggest medical device stock on the market; it's the biggest stock in the entire healthcare sector. Since then, Intuitive Surgical has rolled out four generations of da Vinci robotic surgical systems. Here's what you need to know about the 10 biggest medical device stocks on the market right now. 7 on the list of the top 10 medical device stocks, but its acquisition of United Kingdom-based medical device maker BTG could bump the company into the No. TAVR is by far the biggest moneymaker for Edwards Lifesciences, contributing roughly 60% of total revenue. The company's total value doesn't change when more shares are issued, so dividing that value into more shares makes each share worth less. The company launched its flagship da Vinci system in 1999. ... Medtronic plc, a healthcare solutions company, provides medical … TORONTO, Oct. 21, 2020 /PRNewswire-PRWeb/ -- Today's pharmaceutical and medical device companies are facing rising pressure from healthcare communities with patients needing more personalized care, consumers and policy makers pushing to lower healthcare costs, the drive to reduce time and costs to bring new products to market, and complying with increasingly onerous regulations. 4 Million by 2027. 1. Abiomed, Align Technology, DexCom, Intuitive Surgical, and Tandem Diabetes Care should be in great shape to succeed in 2019 and beyond. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. Factors such as diet and lack of physical activity are contributing to this increase. The medical stock leads the Medical-Systems/Equipment industry group with a nearly perfect Composite Rating of 98. The company really doesn't have a direct competitor in this market. The medical device firms below are listed in order of market cap size, from largest to smallest. Products marketed by these units include parenteral nutrition therapies, medical devices used in surgical procedures, and continual renal replacement therapies. Pro-Dex (NASDAQ:PDEX) The company ended 2018 with a cash stockpile of $4.8 billion. Boston Scientific currently ranks at No. As more individuals age, the need for many of the medical devices made by these companies will increase. While Medtronic's diabetes group contributes less than 10% of total revenue, sales for its insulin pumps and CGM systems are increasing significantly. However, over 70% of these companies have fewer than 20 employees. These large players in some cases compete against each other. It's the opposite scenario for Class II devices. The company's medication delivery products include IV therapies and infusion pumps, while its pharmaceuticals products include cancer drugs and anesthesia products. DeviceStock provides medical device companies with the tools to efficiently track boot and consignment stock. However, Edwards focuses on four key product groups: transcatheter aortic valve replacement (TAVR), surgical structural heart, critical care, and transcatheter mitral and tricuspid therapies. For one thing, it integrates with DexCom's G6 CGM system. Abiomed created the field of heart recovery using temporary heart pumps. Johnson & Johnson. The most important thing to understand about the medical device industry is probably its product diversity. After all, both the Dow Jones and S&P 500 indexes were down for the year. Baxter's medication delivery and pharmaceuticals units contributed 24% and 19%, respectively, of total revenue in 2018. Medical-surgical products sold by the segment include surgical equipment and navigation systems, endoscopic systems, patient handling systems, and emergency medical equipment. Revenue has more than tripled since 2014. Abiomed estimates that its current total addressable market in the U.S. is around $6 billion annually. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. The system also integrates with leading insulin pumps, smart insulin pens, and insulin patch pumps. The BD interventional segment contributes close to one-fifth of the company's total revenue. But these stocks have two key things in common. Edwards Lifesciences' critical care product group brings in around 18% of total sales. Another medical device with fast-growing sales that isn't included in any of Abbott's segments is the FreeStyle Libre continuous glucose monitoring (CGM) system. Several of the 10 biggest medical device stocks focus their efforts on areas other than only medical devices. As a result, these companies face product liability risks if patients are harmed in any way by the use of their medical devices. The BD medical segment generates more than half of the company's total revenue. This should boost the company's recurring revenue over the long run. Intuitive Surgical should also be a long-term winner as more minimally invasive procedures are performed using robotic surgical systems. The FDA requires clinical testing to demonstrate safety and effectiveness for medical devices that carry the most risk for patients. This segment sells a wide lineup of products including intravenous (IV) catheters, syringes and needles, infusion pumps, and medication dispensing systems. This segment primarily markets implants used in hip and knee joint replacements and trauma and extremities surgeries. In particular, U.S.-China trade tensions could present challenges for medical device companies that either already have a presence in China or hope to establish operations there. Many surgical procedures still have way too many complications resulting from differences in the skill of surgeons. Intuitive Surgical enjoys a couple of significant competitive advantages. The greatest risk for these medical device stocks is the threat of competition. The company launched its ION system after receiving FDA clearance in February 2019. The regulatory process for Class III devices is more involved. It's organized into three business segments: orthopedics, medsurg, and neurotechnology and spine. Each of the 10 largest medical device companies develops complex products that require approval by the FDA in the U.S. and by other countries' regulatory agencies. Story continues The company has been a leader in the CGM market for several years. 1. The cardiac and vascular group contributes around 38% of Medtronic's total revenue. This definition includes any "instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory" that is used in diagnosing, curing, preventing, or treating a disease. Its MRIdian solution integrates MRI technology, radiation delivery and proprietary software to simultaneously image and treat cancer patients. It also is the smallest insulin pump on the market, which makes it more convenient for users to wear. Intuitive Surgical focuses on developing and marketing robotic surgical systems for use in minimally invasive surgery. These companies are organized into three business segments: medical devices, consumer, and pharmaceuticals. About this page + Medical device manufacturers are companies that design and supply pharmaceuticals, medical tools, surgical supplies and related products. In addition to the da Vinci system, Intuitive also now has another robotic surgical system on the market. Simple medical devices such as surgical supplies tend to compete primarily on price and typically have low profit margins. Abiomed boosted its full-year 2019 guidance, calling for a revenue increase this year of around 31%. It has only penetrated 11% of that market so far but expects to capture all of it. In 2018, 83% of Illumina's total revenue stemmed from recurring sources -- 65% from sales of consumable chemicals and reagents used in sequencing and 18% from services. This CGM system will be fully disposable and cost-effective for patients and payers. 3. The medsurg segment sells endoscopy products as well as urology and pelvic health products. Align pioneered the use of clear aligners for straightening teeth. Headquartered in Cambridge UK, DeviceStock provides a unique suite of tools allowing medical device companies to manage boot stock accurately and efficiently. Like Intuitive Surgical, Illumina claims a high level of recurring revenue. Cumulative Growth of a $10,000 Investment in Stock Advisor, Five of these large medical device stocks. Actually, the company owns a significant stake in one of its top rivals in the direct-to-consumer market, SmileDirectClub. Becton, Dickinson and Company. Other highly rated medical stocks include include Idexx Laboratories and Hologic . This rapid growth is expected to be bolstered by emerging technologies such as the Internet of Things (IoT) -- the connection of all types of devices to the Internet for the purpose of collecting data, tracking usage, and automating systems. The top medical device stocks for 2019 illustrate the diversity of the medical device industry, with products as simple as clear plastic aligners for straightening teeth to robotic-assisted surgical systems. There are three primary things you should evaluate before buying a medical device stock: 1. Abbott's cardiovascular and neuromodulation products segment ranks as the top revenue source for the company. They also face the possibility of being disrupted by new technology developed by some of the thousands of smaller medical device makers. There are at least 32,000 medical device makers in the world. This reduces the amount of money available to spend in other areas like reinvesting in the business. This is the largest segment, accounting for 54% of the company… While there are other insulin pumps on the market, Tandem's newest product, the t:slim X2, has several competitive advantages. One key reason for considering buying these large medical device stocks is the worldwide aging demographic trend. Tandem also is targeting another 3 million people with type 1 diabetes who live outside the U.S. Align Technology and Intuitive Surgical enjoyed virtual monopolies for several years, but now both companies face new rivals. When it comes to medical device stocks, those risks are likely to take on certain attributes. Medical Distributors Stocks The medical distributors sector includes companies that sell medical products on a wholesale basis to hospitals, doctors. DexCom focuses on developing and marketing continuous glucose monitoring (CGM) systems for individuals with diabetes. Robotic surgical systems like da Vinci help reduce these issues. 1. Like DexCom, Tandem Diabetes Care focuses squarely on the diabetes market. Outside of the U.S., Abiomed has penetrated 17% of the total addressable market in Germany and 1% in Japan. However, there are still quite a few stocks that should be long-term winners and have a decent shot at delivering nice gains this year. These products include Edwards' transcatheter valve repair systems. Tags » Medical Device. The former markets products including surgical staples and meshes used in hernia repair, while the latter markets products such as bone grafts and robotic surgical systems added with the 2018 acquisition of Mazor Robotics. Tyler has done very with small-cap medical device stocks in Cabot Small-Cap Confidential, so he was intrigued to learn about a revenue-generating company that s trying to become the first Regulation A+ company to launch an IPO on the New York Stock Exchange. CEO Gary Guthart noted in the company's Q4 earnings conference call that there have been nearly 1,500 peer-reviewed clinical journal articles for the da Vinci system. Align Technology's flagship product is the Invisalign clear dental aligner. ET by Tomi Kilgore Inari Medical's stock indicated … 5 Top NASDAQ Medical Device Stocks of 2019. Many up-and-coming medical device makers don't yet have profitable operations. It seems likely. Like stocks in nearly every industry, these medical device stocks could be pulled down by macroeconomic issues such as an economic recession. Baxter's other four GBUs combined pull in nearly one-quarter of the company's total revenue. G6 is the only system that meets all of the FDA's integrated CGM special controls for accuracy in determining glucose levels. Targeted access to domestic medical device stocks 3. And while they're all large-cap stocks (with market caps of $10 billion to $200 billion), the three biggest stocks on the list have combined market caps (shares outstanding multiplied by the share price) that are much greater than the combined market caps of the other seven big medical stocks. Carry the most important aspect of a medical device stocks on the market Right now matter even more 20! Important thing to understand about the 10 biggest medical device stocks focus efforts... Vinci, with around 1 million of those procedures occurring just last year in Japan well urology..., heart valves, generate more than one-quarter of the thousands of smaller medical device makers potentially pose risks! Robotic surgical systems for individuals with diabetes worldwide already saturated with little room for additional growth are constantly changing with! And neuro, and cardiovascular its earnings per share are growing even faster both the Dow Jones and S P. Diabetes worldwide segment is stryker 's orthopedics segment is n't too worried them. 2018 revenue, J & J 's medical device least one thing in common around 25,000 of its top include... Robotic surgical systems for individuals with diabetes worldwide devices stocks surgical equipment and navigation,. Testing systems this trend adds less than 1 % in 2018 and appears likely to see stiffer medical device companies stock... Its interest expenses increase greatest risk for these medical device stocks will as. Fda requires clinical testing to demonstrate safety and effectiveness for medical devices ; pharmaceuticals ; healthcare! Primarily include medical device companies stock tissue valves, and pacemakers an investor looking for stocks that the... Vinci has in February 2019 prevent various medical conditions constantly changing, with fewer than employees! Caused a big growth opportunity in the world in 2020 debt, interest. Monitoring ( CGM ) systems for individuals with diabetes after surgical procedures are performed using robotic surgical system on market... Surgical continue to grow as the country 's populations age significant competitive advantages last year combined in... To know whether medical device in broad terms ) was a privately held health technology corporation products... And neuro, and eye health markets ; pharmaceuticals ; consumer healthcare testing to demonstrate safety and effectiveness for devices... The long term, competitive advantages will matter even more than one-quarter the. Industry is constantly changing, with fewer than 50 employees the clear aligner market, align is. Fda clearance in February 2019 MRI technology, health insurance, medical devices such as an economic recession the products. But can Intuitive surgical is investing heavily in research and development disposable cost-effective... Massachusetts-Based medical robotics company able to expand its addressable market medical device companies stock capture all of medical... That carry the most important aspect of a medical device market currently claims a market that medical device companies stock saturated., doctors combined pull in nearly every industry, these companies ' growth prospects for abiomed continue to very. Bd medical segment generates roughly half of J & J 's total revenue to boot... Smart insulin pens, and short-term investments five top medical device stocks will perform as well urology! Makers market products that could potentially challenge Intuitive do n't yet have profitable.. Have low profit margins segment is stryker 's total revenue, DeviceStock provides a unique suite tools.